登录

Yuanxin Technology Raises ¥3 Billion in Series E Funding Round

Mailman 2021-02-18 17:06

圆心科技
https://www.yuanxinjituan.com/
企业数据由 动脉橙 提供支持
互联网医疗服务提供商 | F轮 | 运营中
中国-北京
2021-08-03
融资金额:RMB¥15亿
红杉资本中国基金
查看

(VCBeat) Feb. 9, 2021 -- Beijing Yuanxin Technology Co., Ltd. ("Yuanxin Technology") announced today that it has secured 3 billion yuan in a Series E funding round. This is another round of financing in half a year after the completion of the Series D financing in June 2020. 


The latest round was led jointly by Sequoia Capital China and Tencent, with participation from CITIC Securities, CICC Capital, OrbiMed, Qiming Venture Partners, Kunling Capital, Gopher Asset Management and E fund, etc. Index Capital acted as the financial advisor. 


Yuanxin Technology plans to use the funds to improve its service capacity and the company's competitive advantages in internet medical treatment, drug management, health insurance and other fields, and further optimize the services of "doctor-patient-drug-insurance".


Founded in 2015, Yuanxin Technology is headquartered in Beijing. After nearly 6 years of rapid development, it has established four business segments, including Miaoshou Doctor, Yuanxin Medical Technology, Yuanxin Pharmacy and Yuanxin Huibao, and become a leading comprehensive service platform for medical treatment, medication and payment in China.


In terms of medical treatment, Miaishou Doctors and Miaoshou Yiku have more than 1.3 million registered doctors, with average daily visits of 7 million. Yuanxin Technology has completed the construction and operation of online hospitals for more than 200 physical hospitals in China.


As for medication, Yuanxin Pharmacy has covered more than 80 cities and more than 370 first-class hospitals at grade 3 in China by relying on more than 200 hospital-side and self-run DTP pharmacies to provide drug delivery and pharmaceutical services for patients.


Besides, through the analysis of patients' treatment and medication data, Yuanxin Huibao works with insurance companies to provide more accurate and high-quality insurance services, so as to solve the payment problem for patients and provide better medical services for patients. Currently, the number of insured people of Yuanxin Huibao has exceeded 30 million.


>>>>

About Sequoia Capital China


Sequoia Capital China, as the "entrepreneur behind entrepreneur", focuses on investment in four directions including technology/media, healthcare, consumer goods/modern services and industrial technology. Over the past 15 years, Sequoia Capital China has invested in nearly 600 enterprises with distinctive technical characteristics, innovative business models, and high growth and development potential.


>>>>

About Tencent


Founded in Shenzhen, China, in 1998, Tencent is an internet service portal offering value-added internet, mobile, telecom, and online advertising services. The company is well-known for its communications and social platforms Weixin and QQ.

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。
推荐阅读

天新药业2023年度每股派0.5元股权登记日为6月25日

智通财经 2024-06-19 17:56

药明康德2023年度权益分派:每股派0.98974元

智通财经 2024-06-19 17:54

微泰医疗6月19日斥资12.84万港元回购3.34万股

智通财经 2024-06-19 17:53

Mailman

共发表文章3245篇

最近内容
查看更多
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

相关公司
查看更多

圆心科技

互联网医疗服务提供商

立即沟通

易方达基金

投资管理机构

立即沟通

鲲翎资本

山东的一家投资机构

立即沟通
产业链接
查看更多